Preview

Проблемы Эндокринологии

Расширенный поиск

Диагностика, дифференциальная диагностика и лечение эндогенного гиперкортицизма

https://doi.org/10.14341/probl201056253-63

Аннотация

Обзор литературы посвящен проблеме диагностики, дифференциальной диагностики и лечения эндогенного гиперкортицизма. Описаны этапы диагностики, основные фармакологические тесты, инструментальные методы исследования, а также тактика лечения и наблюдения за пациентами с данной патологией.

Список литературы

1. Марова Е.И., Беляева А.В., Иловайская И.А. Роль эктопированных рецепторов коры надпочечников в патогенезе АКТГ-независимого синдрома Кушинга. Пробл эндокринол 2008; 1: 54: 40-45.

2. Cavagnini F., Pecori Giraldi F. Adrenal Causes of Hypercortisolism, Endocrinology. 5-th ed 2006; 2: 2353-2378.

3. Bertagna X., Orth D.N. Clinical and laboratory findings and results of therapy in 58 patients with adrenocortical tumors admitted to a single medical center (1951 to 1978). Am J Med 1981; 71: 855-875.

4. Дедов И.И., Мельниченко Г.А. Рациональная фармакотерапия заболеваний эндокринной системы и нарушений обмена веществ. М: Литтерра 2006; 488-510.

5. Марова Е.И., Арапова С.Д., Бельченко Л.В. Болезнь Иценко-Кушинга. Метод пособ для врачей. М 2000.

6. Мельниченко Г.А., Марова Е.И., Дзеранова Л.К. и др. Диагностика и лечение нейроэндокринных заболеваний. Метод пособ для врачей. М 2003; 3-16.

7. Nieman L.K., Biller B.M.K., Findling J.W. et al. The Diagnosis of Cushing's Syndrome. An Endocrine Society Clin Pract Guideline J Clin Endocrinol & Metabol 2008; 93: 5: 1526-1540.

8. Kaye T.B., Crapo L. The Cushing Syndrome: An Update on Diagnostic Tests. Ann Intern Med 1990; 112: 6: 434-444.

9. Raff H., Findling J.W. A Physiologic Approach to Diagnosis of the Cushing Syndrome. Ann Intern Med 2003; 138; 12: 980-991.

10. Wood P.J., Barth J.H., Freedman D.B. et al. Evidence for the low dose dexamethasone suppression test to screen for Cushing's syndrome - recommendations for a protocol for biochemistry laboratories. Ann Clin Biochem 1997; 34: Pt 3: 222-229.

11. Гончаров Н.П., Кация Г.В., Марова Е.И. и др. Использование ультрачувствительного метода определения биологически активного свободного кортизола в слюне для оценки глюкокортикоидной функции коры надпочечников. Пробл эндокринол 2008; 3: 27-35.

12. Liu H., Bravata D.M., Cabaccan J., Raff H., Ryzen E. Elevated late-night salivary cortisol levels in elderly male type 2 diabetic veterans. Clin Endocrinol (Oxford) 2005; 63:642-649.

13. Morris D.G., Grossman A.B., Nieman L.K. Cushing's syndrome, 5th ed. Endocrinology 2006; 1: 429-453.

14. Invitti C., Pecori Giraldi F., De Martin M. et al. Diagnosis and management of Cushing's syndrome: Results of an Italian Multicenter study. J Clin Endocrinol Metab 1999; 84: 440-448.

15. Kirk J.M.W., Brain C.E., Carson D.J. et al. Cushing's syndrome caused by nodular adrenal hyperplasia in children with McCune-Albright syndrome. J Pediat 1999; 134: 789-792.

16. Klose M., Kofoed-Enevoldsen A., Ostergaard Kristensen L. Single determination of plasma ACTH using an immunoradiometric assay with high detectability differentiates between ACTH-dependent and independent Cushing's syndrome. Scand J Clin Lab Invest 2002; 62: 33-38.

17. Law A., Hague W.M., Daly J.G. et al. Inappropriate ACTH concentrations in two patients with functioning adrenocortical carcinoma. Clin Endocrinol 1988; 29: 53-62.

18. Slyper A.H., Finding J.W. Use of a two-site immunoradiometric assay to resolve a factitious elevation of ACTH in primary pigmented nodular adrenocortical disease. J Ped Endocrinol 1994; 7: 61-63.

19. Komanicky P., Spark R.F., Melby J.C. Treatment of Cushing's syndrome with trilostane (WIN 24, 540), an inhibitor of adrenal steroid biosynthesis. J Clin Endocrinol Metab 1978; 47: 1042-1051.

20. Aron D.C., Raff H., Findling J.W. Effectiveness versus efficacy: The limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome. J Clin Endocrinol Metab 1997; 82: 1780-1785.

21. Yanovski J.A., Cutler Jr G.B., Doppman J.L. et al. The limited ability of inferior petrosal sinus sampling with corticotropin-releasing hormone to distinguish Cushing's disease from pseudo-Cushing states or normal physiology. J Clin Endocrinol Metab 1993; 77: 503-509.

22. Grossman A.B., Howlett T.A., Perry L. et al. CRH in differential diagnosis of Cushing's syndrome: A comparison with the dexamethasone suppression test. Clin Endocrinol (Oxford) 1988; 29: 167-178.

23. Nieman L.K., Chrousos G.P., Oldfield E.H. et al. The ovine corticotrophin-releasing hormone stimulation test and the dexamethasone suppression test in the differential diagnosis of Cushing's syndrome. Ann Intern Med 1986; 105: 862-867.

24. Pecori Giraldi F., Pivonello R., Ambrogio A.G. et al. The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing's syndrome from pseudo-Cushing's states. Clin Endocrinol (Oxford) 2007; 66: 251-257.

25. Tsagarakis S., Vassiliadi D., Thalassinos N. Endogenous subclinical hypercortisolism: diagnostic uncertainties and clinical implications. J Endocrinol Invest 2006; 29: 471-482.

26. Korbonits M., Bustin S.A., Kojima M. et al. The expression of the growth hormone secretagogue receptor ligand ghrelin in normal and abnormal human pituitary and other neuroendocrine tumors. J Clin Endocrinol Metab 2001; 86: 881-887.

27. Newell-Price J., Perry L., Medbak S. et al. A combined test using desmopressin and corticotrophin-releasing hormone in the differential diagnosis of Cushing's syndrome. J Clin Endocrinol Metab 1997; 82: 176-181.

28. Tsagarakis S., Tsigos C., Vasiliou V. et al. The desmopressin and combined CRH-desmopressin tests in the differential diagnosis of ACTH-dependent Cushing's syndrome: Constraints imposed by the expression of V2 vasopressin receptors in tumors with ectopic ACTH secretion. J Clin Endocrinol Metab 2002; 87: 1646-1653.

29. Дедов И.И., Ситкин И.И., Белая Ж.Е. и др. Значение метода селективного забора крови из нижних каменистых синусов в дифференциальной диагностике АКТГ-зависимого гиперкортицизма. Пробл эндокринол 2009; 6: 32-35.

30. Reincke M. et al. Adrenal incidentalomas: a manifestation of the metabolic syndrome Endocr Res 1996; 22: 4: 757-761.

31. Rossi R., Tauchmanova L., Luciano A. et al. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features. J Clin Endocrinol Metab 2000; 85: 1440-1148.

32. Terzolo M. et al. Subclinical Cushing's Syndrome. Pituitary 2004; 7: 4: 217-223.

33. Reincke M. et al. Subclinical Cushing's syndrome. Endocrinol Metab Clin North Am 2000; 29: 1: 43-56.

34. Reincke M. et al. Preclinical Cushing's syndrome in adrenal «incidentalomas»: comparison with adrenal Cushing's syndrome. J Clin Endocrinol Metab 1992; 75: 3: 826-832.

35. Torlontano M. et al. Pre-Cushing's syndrome not recognized by conventional dexamethasone suppression-tests in an adrenal «incidentaloma» patient. J Endocrinol Invest 1997; 20: 8: 501-504.

36. Valli N. et al. Biochemical screening for subclinical cortisol-secreting adenomas amongst adrenal incidentalomas. Eur J Endocrinol 2001; 144: 401-408.

37. Allolio B., Fassnacht M. Adrenocortical carcinoma: clinical update. J Clin Endocrinol Metab 2006; 91: 2027-2037.

38. Arnaldi G. et al. Adrenal incidentaloma. Braz J Med Biol Res 2000; 33: 10: 1177-1189.

39. Huiras C.M., Pehling G.B., Caplan R.H. Adrenal insufficiency after operative removal of apparently nonfunctioning adrenal adenomas. JAMA 1989; 261: 6: 894-898.

40. Terzolo M. et al. Prevalence of adrenal carcinoma among incidentally discovered adrenal masses. A retrospective study from 1989 to 1994. Gruppo Piemontese Incidentalomi Surrenalici. Arch Surg 1997; 132: 8: 914-919.

41. Ilias I., Chang R., Pacak K. et al. Jugular venous sampling: An alternative to petrosal sinus sampling for the diagnostic evaluation of adrenocorticotropic hormone-dependent Cushing syndrome. J Clin Endocrinol Metabol 2004; 89: 3795-3800.

42. Bourdeau I., Bard C., Noel B. et al. Loss of brain volume in endogenous Cushing's syndrome and its reversibility after correction of hypercortisolism. J Clin Endocrinol Metab 2002; 87: 1949-1954.

43. Hermus A.R., Smals A.G., Swinkels L.M. et al. Bone mineral density and bone turnover before and after surgical cure of Cushing's syndrome. J Clin Endocrinol Metab 1995; 80: 2859-2865.

44. Lindsay J.R., Nansel T., Baid S. et al. Long-term impaired quality of life in Cushing's syndrome despite initial improvement after surgical remission. J Clin Endocrinol Metab 2006; 91: 447-453.


Для цитирования:


., ., ., . Диагностика, дифференциальная диагностика и лечение эндогенного гиперкортицизма. Проблемы Эндокринологии. 2010;56(2):53-63. https://doi.org/10.14341/probl201056253-63

For citation:


Troshina E.A., Bel'tsevich D.G., Molashenko N.V., Gazizova D.O. Diagnosis, differential diagnosis, and treatment of endogenous hypercorticism. Problems of Endocrinology. 2010;56(2):53-63. (In Russ.) https://doi.org/10.14341/probl201056253-63

Просмотров: 183


ISSN 0375-9660 (Print)
ISSN 2308-1430 (Online)